CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-15 | KIES PETER CFO | Sale | −20,000 | $10.69 | $214K | 119,290 |
| 2020-12-15 | KIES PETER CFO | Option exercise · Common Stock Option | −8,750 | 0 | ||
| 2020-12-15 | KIES PETER CFO | Option exercise · Common Stock Option | −11,250 | 33,750 | ||
| 2020-12-15 | Weiner David B. Director | Option exercise | +17,500 | $4.56 | $80K | 844,719 |
| 2020-12-15 | Weiner David B. Director | Sale | −17,500 | $10.71 | $187K | 827,219 |
| 2020-12-15 | Weiner David B. Director | Option exercise · Common Stock Option | −17,500 | 0 | ||
| 2020-12-05 | YARNO WENDY L Director | Option exercise | +4,090 | 28,453 | ||
| 2020-12-05 | YARNO WENDY L Director | Option exercise · Restricted Stock Unit | −4,090 | 0 | ||
| 2020-11-10 | Humeau Laurent Chief Scientific Officer | Sale | −19,466 | $9.75 | $190K | 24,500 |
| 2020-08-10 | Humeau Laurent Chief Scientific Officer | Sale | −19,467 | $19.06 | $371K | 43,966 |
| 2020-07-30 | Kim Jong Joseph Chief Executive Officer | Sale | −100,000 | $21.13 | $2.1M | 1,188,313 |
| 2020-07-15 | KIES PETER CFO | Option exercise | +35,000 | $2.40 | $84K | 154,290 |
| 2020-07-15 | KIES PETER CFO | Sale | −35,000 | $24.95 | $873K | 119,290 |
| 2020-07-15 | KIES PETER CFO | Option exercise · Common Stock Option | −35,000 | 0 | ||
| 2020-06-30 | KIES PETER CFO | Sale | −35,000 | $26.50 | $928K | 119,290 |
| 2020-06-22 | Humeau Laurent Chief Scientific Officer | Sale | −19,467 | $14.70 | $286K | 63,433 |
| 2020-05-20 | BENITO SIMON X Director | Option exercise | +8,750 | $4.60 | $40K | 60,400 |
| 2020-05-20 | BENITO SIMON X Director | Sale | −8,750 | $15.95 | $140K | 51,650 |
| 2020-05-20 | BENITO SIMON X Director | Option exercise · Common Stock Option | −8,750 | 0 | ||
| 2020-05-14 | Weiner David B. Director | Grant or award · Common Stock Options | +13,300 | 13,300 |
Page 29 of 32 · 622 trades